-- FactSetが調査したアナリストによると、Avalo Therapeutics Inc（AVTX）の平均投資判断は「買い」、平均目標株価は44.40ドルです。 （は、北米、アジア、ヨーロッパの主要銀行および調査会社による株式、商品、経済に関する調査レポートを配信しています。調査レポート提供者の方は、こちらからお問い合わせください：https://www..com/contact-us）
Price: $19.53, Change: $+3.27, Percent Change: +20.11%
London's FTSE 100 closed 2.15% higher on Wednesday on signs of a potential US-Iran deal to end the war, while expansion across the UK's private sector accelerated."Trump announced a temporary pause to 'Project Freedom,' a naval operation in the Strait of Hormuz, indicating a potential de-escalation. Oil prices declined following the announcement and continued to fall overnight, driven by expectations of progress toward a peace deal with Iran, as hinted by Trump. Trump's upcoming visit to China adds further complexity, given Beijing's close ties with Tehran and its economic reliance on oil transit through the strait," Danske Bank said.Back home, Britain's private sector output growth accelerated in April, indicating a moderate rise in manufacturing production and in services sector activity, data from S&P Global showed. The seasonally adjusted S&P Global UK PMI Composite Output Index rose to 52.6 from 50.3 in March. The flash estimate stood at 52."[This] improvement could easily prove short-lived as new business intakes remained subdued in comparison to the start of 2026," S&P Global Market Intelligence Economics Director Tim Moore said. "Survey respondents widely noted that the Middle East conflict and subsequent global supply chain disruptions had weighed heavily on business and consumer confidence."In corporate news, alcoholic beverage company Diageo (DGE.L) climbed 6.34% after affirming its fiscal 2026 guidance and logging a 2.3% yearly increase in net sales for the fiscal third quarter ended March 31 to $4.48 billion."While the spirits environment remains challenging, particularly in the US, Diageo's refreshed strategy and increased reinvestment should support a medium-term growth acceleration, we believe," BofA Global Research said. "The US remains a key headwind, with limited visibility on the timing and pace of a recovery, but performance elsewhere in the group is solid. We see further upside from accelerated deleveraging."On the downside, medical device manufacturer Smith & Nephew (SN.L) dropped 3.58% after launching a $500 million share repurchase program, maintaining its outlook for full-year 2026, and posting growth in first-quarter revenue to $1.50 billion from $1.41 billion."We expect investors to be incrementally reassured by the in-line revenue delivery in Q1 and the $500m share buyback programme. However, we do not see these results as materially de-risking 2026 guidance at this stage, and we continue to see potential downside to guidance in future periods," RBC Capital Markets said.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target by $1 to $26, 11.7x our 2026 FFO per share view. This is above office REIT peers but below VNO's three-year average forward multiple (13.6x), as negative re-leasing spreads and high vacancy levels remain despite an improving office outlook. We lower our 2026 FFO view by $0.07 to $2.22 and raise 2027's by $0.08 to $2.40. There is now increased uncertainty around whether the 350 Park Avenue redevelopment will move forward; it was the first specific item mentioned by management on the call. Citadel will ultimately decide whether the $4.5B project moves forward following a public spat with the NYC Mayor. We note that Verizon will not be building out its PENN 2 lease and has chosen to sublet the space, indicating a recent change in plans. Both PENN 1 and PENN 2 have already completed the heavy lifting for leasing, with financial benefits expected in early 2027. VNO's Park Avenue Plaza acquisition is expected to be accretive this year, with rents 40%-50% below market providing future upside.
Tudor, Pickering, Holt on Wednesday maintained its buy rating on the shares of Suncor Energy (SU.TO, SU) with a C$105.00 price target following first-quarter results from the oil producer and refiner."Suncor posted Q1 beats across the board, with downstream throughput/product sales primarily driving better AFFO vs. consensus, with better-than-expected capex further supporting a clean FCF beat. Headline Q1 metrics included beats on AFFO/shr (C$3.39 vs. TPHe/Street C$3.34/3.29) and capex (C$1.08B excl. capitalized interest vs. TPHe/Street C$1.19B/1.22B), which together drove the beat on FCF (C$2.91B vs. TPHe/Street C$2.76B/$2.69B). The beat vs. our model on AFFO owed mainly to much greater Downstream performance with 498mbpd throughput coming in well north of TPHe/Street 477/472, representing 97% utilization on the newly rerated 511mbpd nameplate capacity; C$1.98B AFFO was slightly above TPHe C$1.87B but well north of Street C$1.61B. On Upstream ops, 875mbopd came in modestly below our model but also well above Street, comparing to TPHe/Street 880/868, with the delta vs. TPHe driven by Oil Sands production of 799mbopd vs. TPHe 805, with Syncrude maintenance offsetting record Fort Hills; C$2.89B AFFO vs. TPHe/Street C$2.94B/C$2.83B. E&P was in-line on volumes vs. our model but again well north of Street, at 76mbopd vs. TPHe/Street 75/62; C$0.56B AFFO vs. TPHe/Street $0.41B/C$0.35B," analyst Jeoffrey Lambujon wrote.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $88.79, Change: $-6.26, Percent Change: -6.59%